Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Cerulean Pharma (United States)
h-index: 16
Total citations: 1,422
Total papers: 66
Recent papers from Cerulean Pharma (United States)
Gap scheduling of a PARP inhibitor and nanoparticle TOP1 agent combination avoids synergistic bone marrow toxicity
2025
Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function
Clinical Pharmacology in Drug Development · 2024
Discovery of a Novel Cabazitaxel Nanoparticle–Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin–PEG Copolymer Based Delivery Platform
Journal of Medicinal Chemistry · 2019
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer
Journal of Gastrointestinal Oncology · 2017
CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
Cancer Research · 2016
Clinical Safety of a High Dose of Phycocyanin-Enriched Aqueous Extract from Arthrospira (Spirulina) platensis : Results from a Randomized, Double-Blind, Placebo-Controlled Study with a Focus on Anticoagulant Activity and Platelet Activation
Journal of Medicinal Food · 2016
Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer
Cancer Research · 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical
Molecular Pharmaceutics · 2016
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Proceedings of the National Academy of Sciences · 2013
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Journal of Controlled Release · 2011
CRLX101 (formerly IT-101) – A Novel Nanopharmaceutical of Camptothecin in Clinical Development
Current Bioactive Compounds · 2011